Literature DB >> 28250462

Gout: Risk of premature death in gout unchanged for years.

Chang-Fu Kuo1, Shue-Fen Luo1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28250462     DOI: 10.1038/nrrheum.2017.27

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality.

Authors:  Chang-Fu Kuo; Lai-Chu See; Kuang-Hui Yu; I-Jun Chou; Meng-Jiun Chiou; Shue-Fen Luo
Journal:  Rheumatology (Oxford)       Date:  2012-08-25       Impact factor: 7.580

2.  Hyperuricaemia and gout: time for a new staging system?

Authors:  Nicola Dalbeth; Lisa Stamp
Journal:  Ann Rheum Dis       Date:  2014-04-09       Impact factor: 19.103

3.  The unclosing premature mortality gap in gout: a general population-based study.

Authors:  Mark C Fisher; Sharan K Rai; Na Lu; Yuqing Zhang; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2017-01-25       Impact factor: 19.103

4.  Improved survival in rheumatoid arthritis: a general population-based cohort study.

Authors:  Yuqing Zhang; Na Lu; Christine Peloquin; Maureen Dubreuil; Tuhina Neogi; J Antonio Aviña-Zubieta; Sharan K Rai; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2016-06-23       Impact factor: 19.103

Review 5.  Gout: why is this curable disease so seldom cured?

Authors:  Michael Doherty; Tim L Jansen; George Nuki; Eliseo Pascual; Fernando Perez-Ruiz; Leonardo Punzi; Alexander K So; Thomas Bardin
Journal:  Ann Rheum Dis       Date:  2012-08-03       Impact factor: 19.103

Review 6.  2016 updated EULAR evidence-based recommendations for the management of gout.

Authors:  P Richette; M Doherty; E Pascual; V Barskova; F Becce; J Castañeda-Sanabria; M Coyfish; S Guillo; T L Jansen; H Janssens; F Lioté; C Mallen; G Nuki; F Perez-Ruiz; J Pimentao; L Punzi; T Pywell; A So; A K Tausche; T Uhlig; J Zavada; W Zhang; F Tubach; T Bardin
Journal:  Ann Rheum Dis       Date:  2016-07-25       Impact factor: 19.103

7.  Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Christian Mallen; Weiya Zhang; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2014-01-15       Impact factor: 19.103

8.  Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data.

Authors:  Aidan G O'Keeffe; Irwin Nazareth; Irene Petersen
Journal:  Clin Epidemiol       Date:  2016-05-27       Impact factor: 4.790

9.  Comorbidities in patients with gout prior to and following diagnosis: case-control study.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Christian Mallen; Weiya Zhang; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2014-11-14       Impact factor: 19.103

Review 10.  Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis.

Authors:  L E Clarson; P Chandratre; S L Hider; J Belcher; C Heneghan; E Roddy; C D Mallen
Journal:  Eur J Prev Cardiol       Date:  2013-11-26       Impact factor: 7.804

  10 in total
  6 in total

1.  Cardiovascular Risks in Korean Patients with Gout: Analysis Using a National Health Insurance Service Database.

Authors:  Ki Won Moon; Min Jung Kim; In Ah Choi; Kichul Shin
Journal:  J Clin Med       Date:  2022-04-11       Impact factor: 4.964

Review 2.  Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.

Authors:  Thomas Bardin; Pascal Richette
Journal:  BMC Med       Date:  2017-07-03       Impact factor: 8.775

3.  Association Between Gout and Injury Risk: A National Retrospective Cohort Study.

Authors:  Shih-Hsiang Ou; Chu-Lin Chou; Chia-Wei Lin; Wu-Chien Chien; Te-Chao Fang; Kuo-Cheng Lu; Jin-Shuen Chen
Journal:  Int J Environ Res Public Health       Date:  2020-05-23       Impact factor: 3.390

4.  Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study.

Authors:  Megan Francis-Sedlak; Brian LaMoreaux; Lissa Padnick-Silver; Robert J Holt; Alfonso E Bello
Journal:  Rheumatol Ther       Date:  2020-12-07

5.  Prevalence and treatment of gout among patients with chronic kidney disease in the Irish health system: A national study.

Authors:  Elshaeima Mohammed; Leonard D Browne; Arun Kumar A U; Fahd Adeeb; Alexander D Fraser; Austin G Stack
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

6.  Association Between Chinese Herbal Medicine Therapy and the Risk of Chronic Kidney Disease in Gout Patients.

Authors:  Yan-Zhuan Xiao; Zhi-Zhong Ye; Yuan-Tong Liang; Xin-Peng Chen; Yu-Hsun Wang; Qiang Xu; James Cheng-Chung Wei
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.